AwardedEuropean

Voluntary transparency trial coordination & management

Type
73300000
Estimated value
Not published
To deadline
Ongoing
Knock-outs
n/a
exclusion grounds
Award basis
Best price-quality ratio
Assess manuallyconfidence low

The Universitaire Medisch Centrum Groningen (UMCG) is contracting The George Institute for Global Health (TGI) for project management of international phase 3 clinical drug trials in the field of kidney diseases. The assignment concerns research and development projects (CPV 73300000-5) and is intended for a specialized academic research organization. A negotiated procedure without prior call for competition is used, without a deadline or reported contract value. This offers an interesting opportunity for research companies with global expertise and experience in clinical research.

Contract · European procedure

European
Contract type
Not specified
Estimated value
Estimate not published
Submission deadline
Ongoing
Scope
European
European procedure
Lots
1
1 lots
Main CPV code
Location
Netherlands
CharacteristicsCPV 73EU tender

01What is being requested

The Universitaire Medisch Centrum Groningen (UMCG) is contracting The George Institute for Global Health (TGI) for project management of international phase 3 clinical drug trials in the field of kidney diseases. The assignment concerns research and development projects (CPV 73300000-5) and is intended for a specialized academic research organization. A negotiated procedure without prior call for competition is used, without a deadline or reported contract value. This offers an interesting opportunity for research companies with global expertise and experience in clinical research.

The UMCG wishes to contract The George Institute for Global Health (TGI) for project management tasks of multiple international phase 3 clinical drug trials in the field of kidney diseases. As the sole academic research organization, TGI possesses the necessary expertise, infrastructure, and a global network and patient registry to effectively conduct these complex and large-scale nephrological trials within timelines and in accordance with international quality and GCP guidelines. The assignment includes, among other things, operational project management, quality monitoring, site management

73300000
1Voluntary transparency trial coordination & management

02Outcome

Awarded

The George Institute for Global Health (TGI)

03Exclusion grounds

Exclusion grounds — consult the ESPD
  • No specific exclusion grounds were extracted. In a European tender, the mandatory and discretionary grounds of art. 2.86/2.87 of the Dutch Procurement Act almost always apply — check the European Single Procurement Document (ESPD).

04Bidders in this segment

#Likely bidderFitWins
1The George Institute for Global Health (TGI)Unknown70
2I&O Research B.V.SME6310×
3Amsterdam UMC Research B.V.SME57
4NIVELUnknown57
5KPMG Advisory N.V.SME52
6KplusV B.V.SME51

05Legal themes that may be relevant here

06Frequently asked questions

What is the specific content of the assignment?
The assignment concerns the project management of multiple international phase 3 clinical drug trials in the field of kidney diseases. The activities include operational project management, quality monitoring, site management, and support for international regulatory processes such as FDA, EMA, and local authorities.
Which quality standards must the execution comply with?
The execution of the nephrological trials must be carried out in accordance with international quality guidelines and the applicable GCP guidelines.
What expertise is required for the execution of these studies?
Expertise is required in the field of international phase 3 trials, familiarity with FDA and EMA regulatory processes, and experience with quality monitoring and GCP compliance.

Automatically compiled from the official tender data and documents.

07Estimated value versus the market

p25
€ 165K
median
€ 420K
p75
€ 1,1 mln
deze opdracht

Gegunde waarden in CPV 73 n=469